CARA - Cara Therapeutics, Inc.
| Previous Close | 19.04 |
| Open | 19.24 |
| Bid | 18.75 x 1000 |
| Ask | 19.88 x 2900 |
| Day's Range | 18.64 - 19.54 |
| 52 Week Range | 11.50 - 24.30 |
| Volume | 489,317 |
| Avg. Volume | 664,096 |
| Market Cap | 767.223M |
| Beta (3Y Monthly) | 2.93 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.06 |
| Earnings Date | Aug 3, 2017 - Aug 7, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25.80 |
- Market Realist•4 days ago
Cannabis Updates: New Listings, Price Action, and Ratings
Cannabis Updates: New Listings, Price Action, and RatingsCannabis updateThe cannabis sector showed some weakness last week, and the Horizons Marijuana Life Sciences ETF (HMMJ) lost 3.0% while the ETFMG Alternate Harvest ETF (MJ) lost 3.4%.
- Investopedia•9 days ago
Top Marijuana Stocks on the NASDAQ
The cannabis industry has grown in recent months and years, and many companies in the cannabis and health-related industries have been uplisted to reputable U.S. exchanges. Learn about the marijuana stocks on the Nasdaq.
- ACCESSWIRE•10 days ago
CBD Company to Research Now
HENDERSON, NV / ACCESSWIRE / April 16, 2019 / CBD is becoming a household name in the US. In a recent survey conducted with the Harris Poll, Quartz asked over 2,000 Americans about their use and perceptions ...
- Motley Fool•12 days ago
Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
Both of these biotech stocks have tremendous momentum. Which is more likely to deliver bigger returns in the future?
- ACCESSWIRE•15 days ago
Cara Therapeutics Posts 2018 Revenue 15X over 2017, Questions, Catalysts, and Hurdles Every Marijuana Stock Investor Should be Considering
NEW YORK, NY / ACCESSWIRE / April 11, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Cara Therapeutics, Inc. (CARA), a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors. Traders News Source has created a comprehensive report on the current state of the cannabis market, including an outlook on where the industry may be headed in 2019. This report is a must read for investors in cannabis stocks.
- Motley Fool•17 days ago
Why Cara Therapeutics Stock Jumped 15.1% in March
This small biotech expects to announce results from two clinical studies in 2019.
- Motley Fool•18 days ago
3 Top Biotech Stocks to Buy in April
These three biotech stocks are worth buying this month.
- Motley Fool•19 days ago
3 Top Small-Cap Biotech Stocks for Aggressive Investors
They're risky, but these up-and-coming biotechs could be tremendous winners for investors willing to take on those risks.
- Thomson Reuters StreetEvents•23 days ago
Edited Transcript of CARA earnings conference call or presentation 12-Mar-19 8:30pm GMT
Q4 2018 Cara Therapeutics Inc Earnings Call
- GlobeNewswire•24 days ago
Cara Therapeutics to Present at the 18th Annual Needham Healthcare Conference
STAMFORD, Conn., April 02, 2019 -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a.
Market Realist•24 days agoAnalysts Love Charlotte’s Web Holdings despite Q4 Earnings Miss
Charlotte’s Web Holdings Continues Its Good Run after Strong Q1(Continued from Prior Part)AnalystsCharlotte’s Web Holdings (CWBHF) released its fourth-quarter earnings last week and missed analysts’ estimates for both its top line as well as
Market Realist•28 days agoCharlotte’s Web Holdings Reports Record Harvest in 2018
Key Takeaways from Charlotte’s Web Holdings' Q4 Earnings(Continued from Prior Part)Record harvestCharlotte’s Web Holdings (CWBHF) posted a record harvest of 675,000 pounds last year. The company had produced 63,000 pounds of raw hemp in 2017.
- GlobeNewswire•28 days ago
Analysis: Positioning to Benefit within American Water Works, TripAdvisor, ACADIA Pharmaceuticals, Dril-Quip, Domtar, and Cara Therapeutics — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, March 29, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Market Realist•last month
Charlotte’s Web Holdings Is Outperforming Peers in March
What to Expect from Charlotte’s Web Holdings' Q4 EarningsCharlotte’s Web Holdings Charlotte’s Web Holdings (CWBHF) is scheduled to release its fourth-quarter earnings on March 28 after markets close. The company plans to hold its earnings call
- ACCESSWIRE•last month
Cannabis Breakout Candidates - THC Therapeutics, Inc. (THCT)
HENDERSON, NV / ACCESSWIRE / March 22, 2019 / Many high-profile companies in the cannabis market have posted incredible gains since start of 2019 and this trend looks to continue. The race to profit from ...
- Motley Fool•last month
Here's Why Cara Therapeutics Stock Rose as Much as 13.9% Today
The pharma company announced full-year 2018 operating results and reiterated the road map for the year ahead.
- ACCESSWIRE•last month
These Four Marijuana Stocks Are Raising Eyebrows on Wednesday
CORAL GABLES, FL / ACCESSWIRE / March 13, 2019 / The marijuana stock market has seen an impressive couple months thus far in 2019, despite the cannabis industry still very much in its infancy. Especially in the cannabis sector, there is a considerable amount of smaller companies taking innovative approaches to create cannabis products, ultimately resulting in growing excitement from investors. Leafbuyer Technologies Inc (OTC:LBUY), Tauriga Sciences Inc (TAUG), Cara Therapeutics Inc (CARA), and HEXO Corp (NYSE American: HEXO, TSX: HEXO) are 4 marijuana stocks getting a boost from today's headlines.
Motley Fool•last monthCara Therapeutics Inc (CARA) Q4 2018 Earnings Conference Call Transcript
CARA earnings call for the period ending December 31, 2018.
- CNBC•last month
Stocks making the biggest moves after hours: Switch, Clearwater Paper and more
See which stocks are posting big moves after the bell on March 12.
- Zacks•last month
Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
Cara (CARA) delivered earnings and revenue surprises of 11.86% and 65.26%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•last month
Cara: 4Q Earnings Snapshot
The Stamford, Connecticut-based company said it had a loss of 52 cents per share. The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research ...
- GlobeNewswire•last month
Cara Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
STAMFORD, Conn., March 12, 2019 -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a.
- ACCESSWIRE•last month
Top Cannabis Plays-THC Therapeutics, Inc
HENDERSON, NV / ACCESSWIRE / March 12, 2019 / Year to date, the Global Cannabis Stock Index is up almost 50% in less than three months. It's safe to say investors are bullish on the cannabis. Here are ...
- Zacks•2 months ago
Athersys (ATHX) Q4 Earnings: What's in Store for the Stock?
During Athersys' (ATHX) Q4 conference call, investor focus will be on the company's progress with its investigational MultiStem cell therapy to treat various indications.
- Zacks•2 months ago
Is a Beat in Store for Catabasis (CATB) This Earnings Season?
Catabasis (CATB) progresses with DMD candidate, edasalonexent. However, operating expenses are likely to be lower.
